Mingquan Chen

2.3k total citations · 1 hit paper
40 papers, 1.6k citations indexed

About

Mingquan Chen is a scholar working on Epidemiology, Molecular Biology and Hepatology. According to data from OpenAlex, Mingquan Chen has authored 40 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 10 papers in Molecular Biology and 9 papers in Hepatology. Recurrent topics in Mingquan Chen's work include Liver Disease Diagnosis and Treatment (8 papers), Hepatitis B Virus Studies (6 papers) and Metabolomics and Mass Spectrometry Studies (4 papers). Mingquan Chen is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Hepatitis B Virus Studies (6 papers) and Metabolomics and Mass Spectrometry Studies (4 papers). Mingquan Chen collaborates with scholars based in China, Singapore and Sierra Leone. Mingquan Chen's co-authors include Liang Chen, Xiangjie Li, Chenglong Xiong, Yi Feng, Chong Huang, Zhi Yang, Jun Wang, Jingwei Song, Qi Cheng and Jianming Zheng and has published in prestigious journals such as Cancer Research, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Mingquan Chen

37 papers receiving 1.5k citations

Hit Papers

The ACE2 expression in human heart indicates new potentia... 2020 2026 2022 2024 2020 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingquan Chen China 15 685 389 365 276 177 40 1.6k
Zilong Lu China 20 301 0.4× 162 0.4× 348 1.0× 129 0.5× 99 0.6× 89 1.4k
Lin Liu China 27 156 0.2× 130 0.3× 636 1.7× 343 1.2× 213 1.2× 161 2.2k
Jiawei Zou China 12 1.2k 1.7× 546 1.4× 394 1.1× 118 0.4× 91 0.5× 37 2.1k
Zheng Yang China 19 165 0.2× 99 0.3× 379 1.0× 152 0.6× 65 0.4× 81 1.1k
Wan Zhu China 22 391 0.6× 287 0.7× 657 1.8× 150 0.5× 25 0.1× 74 2.0k
Vipul C. Chitalia United States 30 271 0.4× 108 0.3× 905 2.5× 166 0.6× 180 1.0× 94 2.5k
Yong Luo China 16 302 0.4× 113 0.3× 302 0.8× 167 0.6× 59 0.3× 40 1.1k
Ming Zhong China 22 231 0.3× 110 0.3× 1.0k 2.7× 204 0.7× 117 0.7× 89 2.4k
Johannes Lotz Germany 25 91 0.1× 99 0.3× 269 0.7× 198 0.7× 267 1.5× 70 1.6k
Kazuhiro Ozawa Japan 21 193 0.3× 121 0.3× 369 1.0× 108 0.4× 65 0.4× 97 1.9k

Countries citing papers authored by Mingquan Chen

Since Specialization
Citations

This map shows the geographic impact of Mingquan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingquan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingquan Chen more than expected).

Fields of papers citing papers by Mingquan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingquan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingquan Chen. The network helps show where Mingquan Chen may publish in the future.

Co-authorship network of co-authors of Mingquan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Mingquan Chen. A scholar is included among the top collaborators of Mingquan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingquan Chen. Mingquan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Mingquan, et al.. (2025). Effect of gut symbiotic bacteria Akkermansia muciniphila on aging-related obesity. Biochemical and Biophysical Research Communications. 756. 151606–151606.
2.
Chen, Mingquan, et al.. (2024). Insights into the prognostic value and immunological role of CD74 in pan-cancer. Discover Oncology. 15(1). 222–222. 1 indexed citations
3.
Hu, Wei, et al.. (2023). Clinical risk score for early prediction of recurring SARS-CoV-2 positivity in non-critical patients. Frontiers in Medicine. 9. 1002188–1002188. 2 indexed citations
5.
Wang, Chao, Shengsen Chen, Jia Tang, et al.. (2021). A Critical Role of Peptidylprolyl Isomerase A Pseudogene 22/microRNA-197-3p/Peptidylprolyl Isomerase A Axis in Hepatocellular Carcinoma. Frontiers in Genetics. 12. 604461–604461. 10 indexed citations
6.
Xu, Yunyu, Da Shang, Min Zhang, et al.. (2021). Elevated Serum Tenascin-C Predicts Mortality in Critically Ill Patients With Multiple Organ Dysfunction. Frontiers in Medicine. 8. 759273–759273. 5 indexed citations
7.
Huang, Chong, Lu Lu, Kang‐Kang Yu, et al.. (2021). STOML2 potentiates metastasis of hepatocellular carcinoma by promoting PINK1-mediated mitophagy and regulates sensitivity to lenvatinib. Journal of Hematology & Oncology. 14(1). 16–16. 107 indexed citations
8.
Chen, Liang, Xiangjie Li, Mingquan Chen, Yi Feng, & Chenglong Xiong. (2020). The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovascular Research. 116(6). 1097–1100. 807 indexed citations breakdown →
9.
Chen, Mingquan, et al.. (2019). Excision combined with photodynamic therapy for scrotal Paget’s disease in patients aged over 60 years. The Aging Male. 23(5). 854–859. 5 indexed citations
10.
Zhang, Xiaobo, Dongjie Li, Xiong Chen, et al.. (2018). Transurethral vaporesection of prostate: diode laser or thulium laser?. Lasers in Medical Science. 33(4). 891–897. 6 indexed citations
11.
Liao, Jie, Xiaobo Zhang, Mingquan Chen, et al.. (2018). Transurethral resection of the prostate with preservation of the bladder neck decreases postoperative retrograde ejaculation.. Videosurgery and Other Miniinvasive Techniques. 14(1). 96–101. 11 indexed citations
12.
Chen, Shengsen, Chao Wang, Kang‐Kang Yu, et al.. (2018). Development of a Genetic and Clinical Data-Based (GC) Risk Score for Predicting Survival of Hepatocellular Carcinoma Patients After Tumor Resection. Cellular Physiology and Biochemistry. 48(2). 491–502. 10 indexed citations
13.
Zhao, Qiang, Jianming Zheng, Ning Li, et al.. (2017). Interleukin-23 mediates the pathogenesis of LPS/GalN-induced liver injury in mice. International Immunopharmacology. 46. 97–104. 11 indexed citations
14.
Yu, Kangkang, Qian Li, Qi Cheng, et al.. (2017). MicroRNA-548j inhibits type I interferon production by targeting ZBTB11 in patients with chronic hepatitis B. Biochemical and Biophysical Research Communications. 488(4). 628–633. 11 indexed citations
15.
Lu, Yonghai, Ning Li, Liang Gao, et al.. (2016). Acetylcarnitine Is a Candidate Diagnostic and Prognostic Biomarker of Hepatocellular Carcinoma. Cancer Research. 76(10). 2912–2920. 85 indexed citations
16.
Zheng, Jianming, Ning Li, Chong Huang, et al.. (2016). Role of interleukin-23 in monocyte-derived dendritic cells of HBV-related acute-on-chronic liver failure and its correlation with the severity of liver damage. Clinics and Research in Hepatology and Gastroenterology. 41(2). 147–155. 22 indexed citations
17.
Chen, Shengsen, Kangkang Yu, Chong Huang, et al.. (2016). Dual oxidase 1: A predictive tool for the prognosis of hepatocellular carcinoma patients. Oncology Reports. 35(6). 3198–3208. 17 indexed citations
18.
Yu, Kangkang, Chong Huang, Ning Li, et al.. (2016). Factors associated with significant liver necroinflammation in chronic hepatitis B patients with cirrhosis. Scientific Reports. 6(1). 33093–33093. 6 indexed citations
19.
Yu, Kangkang, Chong Huang, Ning Li, et al.. (2016). The combination of three molecular markers can be a valuable predictive tool for the prognosis of hepatocellular carcinoma patients. Scientific Reports. 6(1). 24582–24582. 19 indexed citations
20.
Yu, Kangkang, et al.. (2015). Hepatic sarcoidosis mimicking liver cancer.. PubMed. 8(6). 9607–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026